.webp)
The global parkinsons disease biomarkers market size accounted for USD 1.35 billion in 2025 and is predicted to increase from USD 1.54 billion in 2026 to approximately USD 4.88 billion by 2035, expanding at a CAGR of 13.80% from 2026 to 2035. The market is driven by the rising demand for early diagnosis and disease-modifying therapies.
The global tau protein targeting therapeutics market size was calculated at USD 1,100.00 million in 2025 and is predicted to increase from USD 1,314.50 million in 2026 to approximately USD 6,534.16 million by 2035, expanding at a CAGR of 19.50% from 2026 to 2035. The rising prevalence of neurodegenerative disorders, along with increased research activities and government healthcare initiatives, is a key driver of market growth.
The global hematopoietic stem cell transplantation market size accounted for USD 11.80 billion in 2025 and is predicted to increase from USD 12.69 billion in 2026 to approximately USD 24.32 billion by 2035, expanding at a CAGR of 7.50% from 2026 to 2035. The rising incidence of blood cancers and advancements in stem cell transplant technologies drive the market.
The global hemophilia market size was estimated at USD 12.50 billion in 2025 and is predicted to increase from USD 13.31billion in 2026 to approximately USD 23.46 billion by 2035, expanding at a CAGR of 6.50% from 2026 to 2035. The market is driven by rising diagnosis rates and advanced prophylactic therapies.
The global non-hodgkin's lymphoma market size was estimated at USD 14.10 billion in 2025 and is predicted to increase from USD 15.00 billion in 2026 to approximately USD 26.22 billion by 2035, expanding at a CAGR of 6.40% from 2026 to 2035. The market is driven by growing prevalence and demand for targeted, convenient treatments, driving significant research and development into novel CAR-T and antibody therapies to improve survival rates and patient convenience.
The global additive manufacturing for medical devices market size accounted for USD 4.60 billion in 2025 and is predicted to increase from USD 5.42 billion in 2026 to approximately USD 23.87 billion by 2035, expanding at a CAGR of 17.90% from 2026 to 2035. The additive manufacturing for medical devices market is driven by demand for patient-specific implants and rapid advancements in biocompatible 3D printing technologies.
The global immunochemistry instruments and reagents market size accounted for USD 26.20 billion in 2025 and is predicted to increase from USD 28.14 billion in 2026 to approximately USD 53.50 billion by 2035, expanding at a CAGR of 7.40% from 2026 to 2035. The immunochemistry instruments & reagents market is driven by growing demand for accurate and rapid diagnostic testing.
The global hospital acquired infection control market size accounted for USD 22.30 billion in 2025 and is predicted to increase from USD 23.79 billion in 2026 to approximately USD 42.65 billion by 2035, expanding at a CAGR of 6.70% from 2026 to 2035. The market is driven by rising incidences of hospital-acquired infections and demand for advanced infection prevention solutions.
The global breast lesion localization methods market size accounted for USD 720.00 million in 2025 and is predicted to increase from USD 770.00 million in 2026 to approximately USD 1,480.00 million by 2035, expanding at a CAGR of 7.47% from 2026 to 2035. The breast lesion localization methods market is driven by rising cases of breast cancer and demand for minimally invasive diagnostics.
The global injectable peptides drugs market size accounted for USD 48.60 billion in 2025 and is predicted to increase from USD 53.07 billion in 2026 to approximately USD 117.18 billion by 2035, expanding at a CAGR of 9.20% from 2026 to 2035. The injectable peptides drug market is driven by the rising prevalence of chronic diseases and the demand for targeted therapies.
The global in vivo CAR-T therapy market size accounted for USD 650.00 million in 2025 and is predicted to increase from USD 861.25 million in 2026 to approximately USD 10,841.07 million by 2035, expanding at a CAGR of 32.50% from 2026 to 2035. The market growth is driven by the rising prevalence of cancer, ongoing advancements in healthcare, and the increasing number of clinical trials focused on in vivo CAR-T therapy.
The global large-scale active stem cell clinical trials market size was calculated at USD 7.20 billion in 2025 and is predicted to increase from USD 8.27 billion in 2026 to approximately USD 28.88 billion by 2035, expanding at a CAGR of 14.90% from 2026 to 2035. The market is growing due to rising clinical trial activity driven by increasing demand for regenerative therapies, advancements in stem cell technologies, and expanding applications in chronic and degenerative diseases.
The global oculoplastic surgery market size was estimated at USD 9.80 billion in 2025 and is predicted to increase from USD 10.46 billion in 2026 to approximately USD 18.74 billion by 2035, expanding at a CAGR of 6.70% from 2026 to 2035. The oculoplastic surgery market is driven by rising demand for cosmetic eye procedures and increasing prevalence of age-related eye disorders.
The global CAR-T therapies for blood cancers market size accounted for USD 6.80 billion in 2025 and is predicted to increase from USD 8.09 billion in 2026 to approximately USD 38.40 billion by 2035, expanding at a CAGR of 18.90% from 2026 to 2035. The CAR-T therapies for blood cancers market is driven by the success of CAR-T cell therapy in treating resistant blood cancers and increasing demand for personalized therapies.
The global DNA-based non-viral technologies market size accounted for USD 5.60 billion in 2025 and is predicted to increase from USD 6.57 billion in 2026 to approximately USD 27.85 billion by 2035, expanding at a CAGR of 17.40% from 2026 to 2035. The market is growing due to rising demand for safer, scalable gene therapies, where non-viral delivery methods offer lower immunogenicity, better repeat dosing potential, and cost-effective manufacturing compared to viral vectors.
The global viral and non-viral vectors market size accounted for USD 9.40 billion in 2025 and is predicted to increase from USD 11.07 billion in 2026 to approximately USD 48.37 billion by 2035, expanding at a CAGR of 17.80% from 2026 to 2035. The viral and non-viral vectors market is driven by rising demand for gene and cell therapies, increasing prevalence of genetic and rare diseases, and rapid advancements in vector engineering technologies.
The global hematology analyzers and reagents market size accounted for USD 7.42 billion in 2025 and is predicted to increase from USD 7.90 billion in 2026 to approximately USD 13.97 billion by 2035, expanding at a CAGR of 6.53% from 2026 to 2035. The increased number of preventive and diagnostic health screenings is the key driver of the global hematology analyzers and reagents market.
The global nerve blocks market size accounted for USD 7.81 billion in 2025 and is predicted to increase from USD 9.00 billion in 2026 to approximately USD 32.15 billion by 2035, expanding at a CAGR of 15.20% from 2026 to 2035. The increased surgical procedure numbers and rapid shift toward opioid-sparing pain management are key drivers of the global nerve blocks market.
The global clinical alarm management market size accounted for USD 3.20 billion in 2025 and is predicted to increase from USD 3.56 billion in 2026 to approximately USD 9.20 billion by 2035, expanding at a CAGR of 11.20% from 2026 to 2035. Factors such as rising alarm fatigue amid government initiatives to promote healthcare IT solutions are expected to boost market growth.
The global chemical API CDMO market size accounted for USD 16.80 billion in 2025 and is predicted to increase from USD 18.36 billion in 2026 to approximately USD 40.88 billion by 2035, expanding at a CAGR of 9.30% from 2026 to 2035. The chemical API CDMO market is driven by increasing outsourcing by pharmaceutical companies, rising complexity of drug molecules, and demand for cost-efficient and scalable manufacturing.
The global chemical drug CDMO market size accounted for USD 13.20 billion in 2025 and is predicted to increase from USD 14.32 billion in 2026 to approximately USD 29.84 billion by 2035, expanding at a CAGR of 8.50% from 2026 to 2035. The market growth is attributed to rising pharmaceutical outsourcing and the increasing need for cost-efficient manufacturing capacity.
The global intracranial pressure monitor market size accounted for USD 2.10 billion in 2025 and is predicted to increase from USD 2.26 billion in 2026 to approximately USD 4.29 billion by 2035, expanding at a CAGR of 7.40% from 2026 to 2035. The market growth is attributed to the rising burden of neurological disorders and increasing adoption of advanced real-time intracranial pressure monitoring technologies in critical care settings.
The global medical device vigilance and patient safety software market size was calculated at USD 1.40 billion in 2025 and is predicted to increase from USD 1.56 billion in 2026 to approximately USD 4.23 billion by 2035, expanding at a CAGR of 11.70% from 2026 to 2035. The growth of the medical device vigilance and patient safety software market is driven by the increasing regulatory compliance requirements, rising focus on patient safety, and the growing need for real-time monitoring and reporting of medical device-related adverse events.
The global metabolic testing equipment market size surpassed USD 1.90 billion in 2025 and is predicted to increase from USD 2.07 billion in 2026 to approximately USD 4.38 billion by 2035, expanding at a CAGR of 8.70% from 2026 to 2035. The market growth is attributed to the rising prevalence of metabolic disorders and advancements in diagnostic technologies.
The global non-clinical information systems market size was estimated at USD 18.20 billion in 2025 and is projected to increase from USD 19.69 billion in 2026 to approximately USD 40.03 billion by 2035, expanding at a CAGR of 8.20% from 2026 to 2035. The market is growing due to rising adoption of digital healthcare solutions that improve operational efficiency, streamline administrative workflows, and support data-driven decision-making across healthcare organizations.
The global atrial fibrillation surgery market size accounted for USD 8.30 billion in 2025 and is predicted to increase from USD 8.91 billion in 2026 to approximately USD 16.95 billion by 2035, expanding at a CAGR of 7.40% from 2026 to 2035. The market growth is attributed to the rising prevalence of atrial fibrillation and the rapid adoption of advanced catheter and surgical ablation technologies.
The global cruciate ligament diagnosis and treatment market size accounted for USD 3.60 billion in 2025 and is predicted to increase from USD 3.86 billion in 2026 to approximately USD 7.22 billion by 2035, expanding at a CAGR of 7.20% from 2026 to 2035. The growing incidence of sports injuries and advancements in surgical techniques are key drivers propelling market expansion.
The global electrophoresis reagents market size accounted for USD 1.80 billion in 2025 and is predicted to increase from USD 1.92 billion in 2026 to approximately USD 3.44 billion by 2035, expanding at a CAGR of 6.70% from 2026 to 2035. The electrophoresis reagents market is driven by rising demand in molecular biology and disease diagnostics.
The global hip reconstruction devices market size accounted for USD 9.30 billion in 2025 and is predicted to increase from USD 9.90 billion in 2026 to approximately USD 17.29 billion by 2035, expanding at a CAGR of 6.40% from 2026 to 2035. The hip reconstruction devices market is driven by the rising prevalence of osteoarthritis and an aging population, which are increasing the demand for joint replacement procedures worldwide.
The global automation, digitization and robotics in cell and gene therapy manufacturing market size accounted for USD 950.00 million in 2025 and is predicted to increase from USD 1,127.65 million in 2026 to approximately USD 5,275.10 million by 2035, expanding at a CAGR of 18.70% from 2026 to 2035. The market is driven by the rising adoption of cutting-edge technologies by both large and small manufacturers to improve the precision of complex therapies.
The global B-cell maturation antigen (BCMA) targeted therapies market size accounted for USD 5.60 billion in 2025 and is predicted to increase from USD 6.62 billion in 2026 to approximately USD 29.81 billion by 2035, expanding at a CAGR of 18.20% from 2026 to 2035. The market is driven by the rising prevalence of multiple myeloma, increasing adoption of advanced immunotherapies such as CAR-T and bispecific antibodies, and strong clinical success of BCMA-targeted treatments in relapsed and refractory patients.
The global inflammatory disease market size accounted for USD 125.00 billion in 2025 and is predicted to increase from USD 133.50 billion in 2026 to approximately USD 241.34 billion by 2035, expanding at a CAGR of 6.80% from 2026 to 2035. The inflammatory disease market is driven by the rising burden of chronic inflammatory disorders and the ongoing need for more effective, targeted therapies.
The global endourology instruments and consumables market size accounted for USD 1.45 billion in 2025 and is predicted to increase from USD 1.56 billion in 2026 to approximately USD 3.10 billion by 2035, expanding at a CAGR of 7.90% from 2026 to 2035. The endourology instruments and consumables market is driven by the rising incidence of kidney stones and the growing adoption of disposable surgical devices.
The global respiratory syncytial virus diagnostic market size accounted for USD 1.50 billion in 2025 and is predicted to increase from USD 1.67 billion in 2026 to approximately USD 4.34 billion by 2035, expanding at a CAGR of 11.20% from 2026 to 2035. This market growth is associated with an elevation in the incidence of respiratory infections, an increasing neonatal population, and a considerable demand for in-vitro diagnostics along with point-of-care services. The pace and precision of RSV detection have been enhanced with the use of diagnostic tools, and this has created several promising prospects for firms in this space.
The global cholestatic pruritus market size accounted for USD 1.40 billion in 2025 and is predicted to increase from USD 1.49 billion in 2026 to approximately USD 2.55 billion by 2035, expanding at a CAGR of 6.20% from 2026 to 2035. The market is expanding due to the increasing prevalence of liver diseases such as ICP and PBS, improved diagnostic methods, and well-developed pipelines for the introduction of novel drugs.
The global amylin analog drugs market size accounted for USD 3.20 billion in 2025 and is predicted to increase from USD 3.47 billion in 2026 to approximately USD 7.10 billion by 2035, expanding at a CAGR of 8.30% from 2026 to 2035. The market is rapidly growing due to the high obesity rate across the globe, technological advancements in developing amylin analogs with high efficiency, and government support in terms of reimbursement policies.
The global day case surgery market size accounted for USD 72.10 billion in 2025 and is predicted to increase from USD 76.79 billion in 2026 to approximately USD 135.34 billion by 2035, expanding at a CAGR of 6.50% from 2026 to 2035. The market is majorly driven by the increase in prevalence of diseases and technological advancements in minimally invasive surgery.
The global ambulatory services market size accounted for USD 89.50 billion in 2025 and is predicted to increase from USD 95.59 billion in 2026 to approximately USD 172.80 billion by 2035, expanding at a CAGR of 6.80% from 2026 to 2035. The ambulatory services market is driven by the rising demand for cost-effective, same-day care and the shift from inpatient to outpatient healthcare settings.
The global inpatient services market size accounted for USD 3.20 trillion in 2025 and is predicted to increase from USD 3.39 trillion in 2026 to approximately USD 5.68 trillion by 2035, expanding at a CAGR of 5.90% from 2026 to 2035. The market is driven by the rising development of hospitals across emerging countries, along with the rising prevalence of chronic ailments and increasing surgical procedures.
The global nursing homes and long-term care facilities market size accounted for USD 532.18 billion in 2025 and is predicted to increase from USD 568.37 billion in 2026 to approximately USD 1,027.47 billion by 2035, expanding at a CAGR of 6.80% from 2026 to 2035. The market growth is attributed to the rapidly aging global population and rising demand for long-term care services.
The global preventive medicine market size accounted for USD 420.00 billion in 2025 and is predicted to increase from USD 454.02 billion in 2026 to approximately USD 915.18 billion by 2035, expanding at a CAGR of 8.10% from 2026 to 2035. The preventive medicine market is driven by the rising prevalence of chronic diseases, growing health awareness, and increasing focus on early intervention.
The global nanomechanical testing market size accounted for USD 1.10 billion in 2025 and is predicted to increase from USD 1.19 billion in 2026 to approximately USD 2.42 billion by 2035, expanding at a CAGR of 8.20% from 2026 to 2035. The nanomechanical testing market is driven by rising demand for precise nanoscale material characterization across advanced industries.
The global stem cell umbilical cord blood market size accounted for USD 18.57 billion in 2025 and is predicted to increase from USD 19.49 billion in 2026 to approximately USD 30.16 billion by 2035, expanding at a CAGR of 4.97% from 2026 to 2035. The market is experiencing healthy growth because of the rising demand for regenerative medicine and sophisticated methodologies of therapy.
The global transradial access market size accounted for USD 2.50 billion in 2025 and is predicted to increase from USD 2.71 billion in 2026 to approximately USD 5.55 billion by 2035, expanding at a CAGR of 8.30% from 2026 to 2035. The market is driven by increasing demand for minimally invasive procedures, growing prevalence of cardiac disorders, and ongoing technological advancements in catheters.
The global flexible and semi-rigid ureteroscopy market size accounted for USD 1.50 billion in 2025 and is predicted to increase from USD 1.61 billion in 2026 to approximately USD 3.09 billion by 2035, expanding at a CAGR of 7.50% from 2026 to 2035. The market is driven by the rising incidence of urologic conditions and ongoing advancements in healthcare technologies.
The global IVF services market size was estimated at USD 50.80 billion in 2025 and is predicted to increase from USD 54.10 billion in 2026 to approximately USD 95.36 billion by 2035, expanding at a CAGR of 6.50% from 2026 to 2035. The market growth is attributed to rising infertility rates, delayed parenthood trends, and continuous advancements in assisted reproductive technologies.
The global veterinary urinalysis market size accounted for USD 1.10 billion in 2025 and is predicted to increase from USD 1.17 billion in 2026 to approximately USD 2.05 billion by 2035, expanding at a CAGR of 6.40% from 2026 to 2035. The market growth is attributed to the rising adoption of preventive animal healthcare and advancements in veterinary urinalysis technologies.
The global AI in omics studies market size accounted for USD 1.25 billion in 2025 and is predicted to increase from USD 1.47 billion in 2026 to approximately USD 6.11 billion by 2035, expanding at a CAGR of 17.20% from 2026 to 2035. The market is rapidly growing due to the increasing demand for precision medicine, accelerated drug development to combat rare disease burden, rapid AI adoption by the healthcare industry, and advancements in AI technologies.
The global AI-powered embryo selection market size accounted for USD 320.00 million in 2025 and is predicted to increase from USD 379.20 million in 2026 to approximately USD 1,747.16 million by 2035, expanding at a CAGR of 18.50% from 2026 to 2035. The market is driven by ongoing advancements in machine learning, increasing success rates in IVF treatments, and the rising demand for personalized fertility solutions.
The global montelukast sodium market size accounted for USD 1.07 billion in 2025 and is predicted to increase from USD 1.13 billion in 2026 to approximately USD 1.88 billion by 2035, expanding at a CAGR of 5.80% from 2026 to 2035. The montelukast sodium market is driven by growing demand for effective treatments for respiratory disorders and allergies.